trial · primary record
Tadalafil
Duchenne Muscular Dystrophy
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 12 |
| Primary completion | 2025-09-08 |
| Primary endpoint | Percent Change in Post-contractile BOLD Signal Relative to Resting Condition |
| Registry ID | NCT05195775 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:27.418Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05195775
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.